Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 6.0B | 6.1B | 6.1B | 6.0B |
| Cost of revenue | 3.3B | 3.3B | 3.3B | 3.3B |
| Gross profit | 2.7B | 2.8B | 2.8B | 2.7B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | -13M | — | — | -15M |
| Other operating expenses | 359M | 281M | 354M | 336M |
| Operating income | 2.4B | 2.5B | 2.4B | 2.4B |
| Non operating interest income | ||||
| Income | — | 52M | 0 | 24M |
| Expense | 322M | 312M | 314M | 319M |
| Other income expense | 65M | 16M | 87M | 64M |
| Pretax income | 2.1B | 2.3B | 2.2B | 2.2B |
| Tax provision | 501M | 519M | 518M | 511M |
| Net income | 1.6B | 1.8B | 1.7B | 1.7B |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | 3.1B | 3.2B | 3.1B | 3.1B |
| Net income from continuing op. | 1.6B | 1.8B | 1.7B | 1.7B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |